Fig. 1 · Structure
Documents & Downloads
IDX184
HCV Inhibitor
IDX184 is a potent inhibitor of hepatitis C virus (HCV) replication with a primary action on HCV polymerase, exhibiting an IC50 of 0.31 μM and a Ki of 52.3 nM. This compound demonstrates strong oral bioavailability, making it a valuable tool in the study of HCV infection. IDX184 is suitable for research applications focused on antiviral drug development and understanding HCV biology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1036915-08-8 |
| Applications | HCV Inhibitor |
| Formula | C25H35N6O9PS |
| Molecular Weight | 626.62 |
| SMILES | C[C@]([C@](O[C@@H]1CO[P](NCC2=CC=CC=C2)(OCCSC(C(C)(C)CO)=O)=O)([H])N3C(NC(N)=NC4=O)=C4N=C3)([C@@H]1O)O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.